Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?

Autor: Souza MDR; Health Science Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Parasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil., da Paz WS; Parasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Tropical Medicine Graduate Program, Universidade Federal de Pernambuco, Recife, Brazil., Sales VBDS; Department of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil., de Jesus GFH; Department of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil., Tavares DDS; Department of Health Education, Universidade Federal de Sergipe, Lagarto, Brasil., Lima SVMA; Department of Nursing, Universidade Federal de Sergipe, Lagarto, Brasil., Sousa ÁFL; Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal., de Melo EV; Department of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil., do Carmo RF; College of Pharmaceutical Sciences, Federal University of Vale do São Francisco (UNIVASF), Petrolina, Brazil., de Souza CDF; Department of Medicine, Universidade Federal de Alagoas, Arapiraca, Brazil., Bezerra-Santos M; Health Science Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Parasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Department of Morphology, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Laboratory of Immunology and Molecular Biology, University Hospital, Universidade Federal de Sergipe, Aracaju, Brazil.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2022 Jun 29; Vol. 13, pp. 891711. Date of Electronic Publication: 2022 Jun 29 (Print Publication: 2022).